Drug intelligence / Profile preview

methylnicotinate

Development stage
Unknown
Modality
Small Molecules
Administration
Topical
01

Overview

Methyl nicotinate is the methyl ester of nicotinic acid (niacin). It acts as a peripheral vasodilator when administered topically, leading to increased local blood flow by vasodilation of dermal capillaries, typically resulting in cutaneous erythema. Its pharmacological effects are thought to be mediated by the local release of prostaglandins, which relax vascular smooth muscle. Upon skin penetration, it is hydrolyzed to nicotinic acid and methanol. Main uses are as a rubefacient in over-the-counter topical analgesics for the relief of muscle and joint pain, and as a skin-conditioning agent in cosmetics. It is approved for use as an ingredient in external analgesic drug products and as a flavoring agent.

Brand names
NuviraRalgex
Other names
3-pyridinecarboxylic acid methyl esternicotinic acid methyl estermethyl 3-pyridinecarboxylatemethyl3-pyridinecarboxylatemethyl-3-pyridinecarboxylatemethyl pyridine-3-carboxylatenicomethnikomet3-(methoxycarbonyl)pyridinemethyl ester of pyridine-3-carboxylic acid3-(carbomethoxy)pyridinem-(methoxycarbonyl)pyridinemethyl niacinmethyl nictinatenicotinato de metilanicotinato di metilenicotinato de metilonicotinate de méthylemethylpyride-3-carboxylatemethylpyride3-carboxylatemethylpyride 3-carboxylateFEMA 3709FEMA3709FEMA-3709

Beyond the preview

Go deeper on methylnicotinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylnicotinate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call